Chlorhexidine or Povidone-Iodine for abdominal hysterectomy?
BACKGROUND AND PURPOSE:
Uppal et. al. (Obstetrics and Gynecology, 2017) compared preoperative chlorhexidine-alcohol with povidone-iodine for benign abdominal hysterectomy
Retrospective Cohort Study (2012-2015)
Multivariable logistic regression and propensity score (to address indication bias) to test associations
Surgical site infection within 30 days
4,259 abdominal hysterectomies
Majority of patients had chlorhexidine-alcohol as a skin prep
Overall unadjusted surgical site infection was 29.9%
Comparing chlorhexidine-alcohol to povidone-iodine
Adjusted odds ratio 0.56 (95% CI 0.37–0.85; P=.01)
Had 44% lower odds of developing a surgical site infection
Propensity score matching (one to one), where none of the demographics and risk factors differed significantly between groups, confirmed logistic regression modeling and likewise found a lower percentage of infection in the chlorhexidine-alcohol group compared with povidone-iodine group (1.5% v. 4.7%)
Use of chlorhexidine-alcohol skin prep has 44% lower odds of resulting in a surgical site infection compared with povidone-iodine
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan